Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
34%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
IHE
43
HOLDINGS
15%
ALSO IN MEDX
MEDX
27
HOLDINGS
22%
ALSO IN IHE
SECTOR DRIFT (IHE minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 25.6% | 17.4% | 17.4% |
|
JOHNSON & JOHNSON | 22.7% | 5.1% | 5.1% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% | 4.4% | 4.2% |
|
MERCK & CO. INC. | 4.5% | 3.4% | 3.4% |
|
PFIZER INC | 4.0% | 3.4% | 3.4% |
IHE Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 17.5% |
|
ELI LILLY & CO | 8.2% |
|
VIATRIS, INC. | 4.1% |
|
ROYALTY PHARMA PLC CLASS A | 4.0% |
|
ELANCO ANIMAL HEALTH, INC. | 3.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
ZOETIS INC | 3.0% |
|
CORCEPT THERAPEUTICS INC | 2.6% |
|
AXSOME THERAPEUTICS, INC. | 2.0% |
|
CRINETICS PHARMACEUTICALS INC | 1.5% |
IHE Underweight Relative to MEDX
|
ABBVIE INC | -8.6% |
 |
NOVARTIS AG-ADR | -6.4% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
|
IONIS PHARMACEUTICALS, INC. | -5.1% |
|
ALNYLAM PHARMACEUTICALS INC | -5.0% |
|
AMGEN INC | -3.8% |
|
ALKERMES PLC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |
|
BIOGEN IDEC INC | -2.7% |